Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06352060 · ClinicalTrials.gov registry record
Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
A clinical trial, sponsored by Kansas City Heart Rhythm Research Foundation.
- Completed
- Registry status
- 598
- Enrollment target
NCT06352060: Completed study, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT06352060 is a clinical trial that has completed, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 598 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06352060 has completed, sponsored by Kansas City Heart Rhythm Research Foundation.
- COMPLETED
- Registry status
- 598 participants
- Enrollment target
Study Summary
Observational, multi-center, retrospective study to evaluate the use of ICM (implantable cardiac monitor) versus traditional, non-ICM (non-implantable cardiac monitor) methods such as ECGs (electrocardiogram), Holter, and mobile cardiac outpatient telemetry (MCOT) units.
Primary Outcome
Number of patients with freedom from AF, OAC and AAD Use after 12 months
Interventions
- OTHER No intervention or administration will be performed due to the observational nature of the study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2021-12-31 |
What the finished NCT06352060 record still lists
NCT06352060 is an observational study that tracks outcomes without assigning an intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention or administration will be performed due to the observational nature of the study is the first listed.
NCT06352060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06352060 about?
NCT06352060 is a clinical study titled "Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study". Observational, multi-center, retrospective study to evaluate the use of ICM (implantable cardiac monitor) versus traditional, non-ICM (non-implantable cardiac monitor) methods such as ECGs (electrocardiogram), Holter, and mobile cardiac outpatient telemetry (MCOT) units.
What is the current status of trial NCT06352060?
This trial is currently completed. The enrollment target is 598 participants. The study started on 2018-01-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT06352060?
The interventions under investigation include: No intervention or administration will be performed due to the observational nature of the study (OTHER).
Who is sponsoring clinical trial NCT06352060?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI